Maruyama, Kazuo
Teikyo University,
Japan
2025 Rank: 113577
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 770 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 113577 | 127838 |
| Total Cites | 448 | 476 |
| H-index | 8 | 8 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 32 | 32 |
| Number of Single+First Authored Papers | 48 | 48 |
| Total Cites to Single+First Authored Papers | 67 | 67 |
| Number of Single+First+Last Authored Papers | 112 | 112 |
| Total Cites to Single+First+Last Authored Papers | 146 | 159 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 360 | 370 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.29 |
| Self-Citation Percentage |
5.88%
|
|
Maruyama, Kazuo
Teikyo University,
Japan
2024 Rank: 96058
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 596 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 96058 | 93817 |
| Total Cites | 440 | 523 |
| H-index | 8 | 9 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 38 | 38 |
| Number of Single+First Authored Papers | 47 | 47 |
| Total Cites to Single+First Authored Papers | 70 | 70 |
| Number of Single+First+Last Authored Papers | 119 | 119 |
| Total Cites to Single+First+Last Authored Papers | 148 | 173 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 355 | 372 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.41 |
| Self-Citation Percentage |
15.87%
|
|
Maruyama, Kazuo
Teikyo University,
Japan
2023 Rank: 85297
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 554 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 85297 | 84399 |
| Total Cites | 479 | 554 |
| H-index | 9 | 9 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 42 | 42 |
| Number of Single+First Authored Papers | 47 | 47 |
| Total Cites to Single+First Authored Papers | 90 | 90 |
| Number of Single+First+Last Authored Papers | 119 | 119 |
| Total Cites to Single+First+Last Authored Papers | 172 | 203 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 397 | 408 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.36 |
| Self-Citation Percentage |
13.54%
|
|
Maruyama, Kazuo
Teikyo University,
Japan
2022 Rank: 79739
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 520 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 79739 | 87779 |
| Total Cites | 484 | 561 |
| H-index | 9 | 9 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 38 | 38 |
| Number of Single+First Authored Papers | 48 | 48 |
| Total Cites to Single+First Authored Papers | 63 | 65 |
| Number of Single+First+Last Authored Papers | 120 | 120 |
| Total Cites to Single+First+Last Authored Papers | 164 | 190 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 385 | 400 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.40 |
| Self-Citation Percentage |
13.73%
|
|
Maruyama, Kazuo
Teikyo University,
Japan
2021 Rank: 56871
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 355 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 56871 | 53777 |
| Total Cites | 749 | 865 |
| H-index | 11 | 12 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 82 | 82 |
| Number of Single+First Authored Papers | 47 | 47 |
| Total Cites to Single+First Authored Papers | 150 | 151 |
| Number of Single+First+Last Authored Papers | 111 | 111 |
| Total Cites to Single+First+Last Authored Papers | 288 | 335 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 614 | 644 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.34 |
| Self-Citation Percentage |
13.41%
|
|
Maruyama, Kazuo
Teikyo University,
Japan
2020 Rank: 60171
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 350 out of 94611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 60171 | 65125 |
| Total Cites | 552 | 638 |
| H-index | 10 | 11 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 63 | 63 |
| Number of Single+First Authored Papers | 47 | 47 |
| Total Cites to Single+First Authored Papers | 108 | 109 |
| Number of Single+First+Last Authored Papers | 110 | 110 |
| Total Cites to Single+First+Last Authored Papers | 195 | 224 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 469 | 492 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.30 |
| Self-Citation Percentage |
13.48%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.